– USA, CA – Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, today announced that Patrick F. Williams has been appointed Chief Financial Officer, Senior Vice President, and Treasurer, effective immediately. Mr. Williams brings with him nearly 20 years of financial management experience and public company experience. He succeeds Matthew Pigeon, who is stepping down from his role as Chief Financial Officer and Senior Vice President to pursue other opportunities.
Jeffrey Nugent, Chairman and Chief Executive Officer of Sientra, said, “Sientra is approaching a major inflection point in our business as we transition through our precision launch, establish uninterrupted manufacturing supply, and approach a period of strong growth. Patrick’s executive leadership and corporate finance experience in the medical device arena and specifically in aesthetics recently as SVP and CFO of ZELTIQ, make him well equipped to help guide Sientra through this period and beyond. In previous roles, his contributions were integral in leading companies through the same magnitude of growth that we intend to achieve moving forward. We expect his contributions across finance, operations, and corporate development to be vital in executing our near and long term corporate objectives.”
Mr. Nugent continued, “I would also like to thank Matt for his dedication to Sientra and for his valuable contributions in his nearly six years with the Company. We wish him the best in his future endeavors.”
Mr. Williams said, “I am incredibly excited to join Sientra. The company has an outstanding opportunity to leverage its industry leading clinical data, differentiated products, strong relationships with board certified plastic surgeons and diversifying offering to evolve into a world class aesthetics organization. I look forward to working with the team to accomplish this objective.”
Most recently, Mr. Williams served as Senior Vice President and Chief Financial Officer at ZELTIQ Aesthetics (NASDAQ:ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. Mr. Williams was at ZELTIQ for approximately four years and was responsible for executive management of the finance and investor relations functions, development of the worldwide budget and forecast, and implementation of necessary infrastructure changes to support top-line growth and operating margin expansion. Prior to ZELTIQ, Mr. Williams served as Vice President of Strategy and Investor Relations, and Vice President of Finance and Investor Relations at NuVasive, a medical device company focused on developing minimally invasive surgical products for the spine. Mr. Williams currently serves on the Board of Directors of Miramar Labs, a medical device company that markets miraDRY®, a system designed for the treatment for hyperhidrosis.
Mr. Williams received an MBA in Finance and Management from San Diego State University and a Bachelor of Arts in Economics from University of California, San Diego.
Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company committed to making a difference in patients’ lives by enhancing their body image, growing their self-esteem and restoring their confidence. The Company was founded to provide greater choice to board-certified plastic surgeons and patients in need of medical aesthetics products. The Company has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants and breast tissue expanders exclusively to board-certified and board-admissible plastic surgeons and tailors its customer service offerings to their specific needs. The Company also offers a range of other aesthetic and specialty products including bioCorneum®, the professional choice in scar management.
For more information, visit www.sientra.com
- Disclaimer - News, data and statement included in this release are intended exclusively for general information purposes. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of the information. No data or statement in this release should be considered for decisions about securities referred. Product and brand names used in this release maybe trademarks or registered trademarks of their respective owners.
Comments are closed.